The TGA Compliance Principles 2026 and 2027 provide a structured, risk-based framework for monitoring, enforcing, and supporting compliance with the Therapeutic Goods Act 1989. ...more
Therapeutic Goods Administration ,Compliance
February 22, 2026•5 min read

By transforming chaos into control, businesses can leverage regulatory compliance as a tool for market differentiation, operational excellence, and sustainable growth ...more
Leadership Values ,Compliance
February 09, 2026•5 min read

Investing in QSN’s capability-building approach transforms compliance from a temporary activity into a sustainable organisational strength, reinforcing quality culture, reducing risk, and enabling lon... ...more
QMS ,Compliance
February 04, 2026•5 min read

Identifying and addressing operational knowledge gaps is critical for organisations operating in regulated environments such as therapeutic goods manufacturing, biotechnology, and testing laboratories ...more
Quality Training ,Compliance
February 03, 2026•5 min read

QSN Academy provides specialised GMP and regulatory compliance training that upskills staff, embeds operational knowledge, and fosters a culture of accountability. By implementing structured, interact... ...more
Compliance
January 13, 2026•4 min read

Regulatory complexity and compliance burden are inherent challenges in the therapeutic goods and biotechnology sectors. Startups must contend with fragmented, technical, and constantly evolving global... ...more
Compliance
January 13, 2026•4 min read
